Sun Pharmaceutical Industries Inc. has voluntarily recalled 9,552 bottles of Divalproex Sodium (valproate) Delayed-Release Tablets, USP 500mg. This medication, primarily used to treat seizures and bipolar disorder, was found to fail dissolution testing during routine stability checks. No incidents or injuries have been reported to date, and the product was distributed to pharmacies nationwide.
The tablets may not dissolve correctly in the digestive system, which can prevent the medication from being absorbed at the proper rate. This failure could lead to the medication being less effective at controlling symptoms or causing unexpected side effects.
You have 2 options:
Distributed by Sun Pharmaceutical Industries, Inc., Cranbury, NJ; Manufactured by Sun Pharmaceutical Industries, Ltd., Gujarat, India.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.